Literature DB >> 13518372

Further studies on urinary aldosterone in human arterial hypertension.

J GENEST, E KOIW, W NOWACZYNSKI, G LEBOEUF.   

Abstract

Entities:  

Keywords:  ALDOSTERONE/in urine; HYPERTENSION/urine in

Mesh:

Substances:

Year:  1958        PMID: 13518372     DOI: 10.3181/00379727-97-23843

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  18 in total

1.  Clinical connotations of the experimental hypertensions.

Authors:  A C CORCORAN
Journal:  Can Med Assoc J       Date:  1959-08-01       Impact factor: 8.262

Review 2.  ALDOSTERONE IN CLINICAL MEDICINE.

Authors:  E G BIGLIERI; P E SLATON
Journal:  Calif Med       Date:  1964-09

3.  PRIMARY ALDOSTERONISM: DIAGNOSIS AND SURGICAL TREATMENT.

Authors:  J W GILBERT; N H BELL; F C BARTTER
Journal:  Ann Surg       Date:  1963-08       Impact factor: 12.969

4.  DIURNAL CYCLE OF RENAL HEMODYNAMICS AND EXCRETION OF CHLORIDE AND POTASSIUM IN HYPERTENSIVE SUBJECTS.

Authors:  A I VAGNUCCI; L G WESSON
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

5.  Aldosterone secretion in hypertensive diseases.

Authors:  C L COPE; M HARWOOD; J PEARSON
Journal:  Br Med J       Date:  1962-03-10

6.  Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion.

Authors:  C C CARPENTER; J O DAVIS; C R AYERS
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

7.  Angiotensin, aldosterone and human arterial hypertension.

Authors:  J GENEST
Journal:  Can Med Assoc J       Date:  1961-02-25       Impact factor: 8.262

8.  Steroid formation by adrenal tissue from hypertensives.

Authors:  D Y COOPER; J C TOUCHSTONE; J M ROBERTS; W S BLAKEMORE; O ROSENTHAL
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

9.  Aldosterone secretion and primary and malignant hypertension.

Authors:  J H LARAGH; S ULICK; V JANUSZEWICZ; Q B DEMING; W G KELLY; S LIEBERMAN
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

10.  THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE.

Authors:  P Biron; E Koiw; W Nowaczynski; J Brouillet; J Genest
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.